SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001387131-20-006307
Filing Date
2020-07-10
Accepted
2020-07-10 16:37:38
Documents
1
Group Members
DAVID BONDERMANJAMES G. COULTER

Document Format Files

Seq Description Document Type Size
1 SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP fusn-sc13d_063020.htm SC 13D 79923
  Complete submission text file 0001387131-20-006307.txt   81528
Mailing Address C/O TPG GLOBAL, LLC 301 COMMERCE STREET, SUITE 3300 FORT WORTH TX 76102
Business Address C/O TPG GLOBAL, LLC 301 COMMERCE STREET, SUITE 3300 FORT WORTH TX 76102 817-871-4000
TPG Group Holdings (SBS) Advisors, Inc. (Filed by) CIK: 0001495741 (see all company filings)

IRS No.: 271650453 | State of Incorp.: DE
Type: SC 13D

Mailing Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6
Business Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6 289-799-0891
Fusion Pharmaceuticals Inc. (Subject) CIK: 0001805890 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-91552 | Film No.: 201023512
SIC: 2836 Biological Products, (No Diagnostic Substances)